TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review June 2, 1978
TCL Archive NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman October 21, 1994